BridgeBio

About:

BridgeBio focuses on the development and commercialization of precision medicines for various genetic diseases and cancers.

Website: http://bridgebio.com

Twitter/X: bridgebiopharma

Top Investors: Blue Owl, Hercules Capital, Sequoia Capital, Perceptive Advisors, Kohlberg Kravis Roberts

Description:

BridgeBio is a biotechnology company that focuses on genetic disease therapies and develops those assets with the right approach in supporting R&D. BridgeBio creates a bridge from advancements in genetic science to patients with unmet needs via the entrepreneurial engine required to make life-changing medicines as rapidly as possible. BridgeBio's mission is to discover, create, test, and deliver transformative medicines to treat patients with genetic diseases.